CMA function becomes impaired in atherosclerosis progression, leading to NLRP3 inflammasome activation and IL-1β secretion and promoting vascular inflammation and atherosclerosis progression (Qiao et al., 2021). Here, NLRP3 is linked to atherosclerosis.